p53-dependent and -independent functions of the Arf tumor suppressor

被引:83
作者
Sherr, C. J. [1 ]
Bertwistle, D. [1 ]
Den Besten, W. [1 ]
Kuo, M. -L. [1 ]
Sugimoto, M. [1 ]
Tago, K. [1 ]
Williams, R. T. [1 ]
Zindy, F. [1 ]
Roussel, M. F. [1 ]
机构
[1] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA
来源
MOLECULAR APPROACHES TO CONTROLLING CANCER | 2005年 / 70卷
关键词
CELL-CYCLE INHIBITORS; NF-KAPPA-B; C-MYC; INK4A LOCUS; NUCLEOLAR LOCALIZATION; PROTEIN MODIFICATION; DNA-DAMAGE; E3; LIGASE; P19(ARF); P53;
D O I
10.1101/sqb.2005.70.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Ink4a-Arf locus encodes two closely wedded tumor suppressor proteins (p16(Ink4a) and p19(Arf)) that inhibit cell proliferation by activating Rb and p53, respectively. With few exceptions, the Arf gene is repressed during mouse embryonic development, thereby helping to limit p53 expression during organogenesis. However, in adult mice, sustained hyperproliferative signals conveyed by somatically activated oncogenes can induce Arf gene expression and trigger a p53 response that eliminates incipient cancer cells. Disruption of this tumor surveillance pathway predisposes to cancer, and inactivation of INK4a-ARF by deletion, silencing, or mutation has been frequently observed in many forms of human cancer. Although it is accepted that much of Arf's tumor-suppressive activity is mediated by p53, more recent genetic evidence has pointed to additional p53-independent functions of Arf, including its ability to inhibit gene expression by a number of other transcription factors. Surprisingly, the enforced expression of Arf in mammalian cells promotes the sumoylation of several Arf-interacting proteins, implying that Arf has an associated catalytic activity. We speculate that transcriptional down-regulation in response to Arf-induced sumoylation may account for Arf's p53-independent functions.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 100 条
[1]   THE C-MYC ONCOGENE DRIVEN BY IMMUNOGLOBULIN ENHANCERS INDUCES LYMPHOID MALIGNANCY IN TRANSGENIC MICE [J].
ADAMS, JM ;
HARRIS, AW ;
PINKERT, CA ;
CORCORAN, LM ;
ALEXANDER, WS ;
CORY, S ;
PALMITER, RD ;
BRINSTER, RL .
NATURE, 1985, 318 (6046) :533-538
[2]   Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice [J].
Artandi, SE ;
Chang, S ;
Lee, SL ;
Alson, S ;
Gottlieb, GJ ;
Chin, L ;
DePinho, RA .
NATURE, 2000, 406 (6796) :641-645
[3]   Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics [J].
Aslanian, A ;
Iaquinta, PJ ;
Verona, R ;
Lees, JA .
GENES & DEVELOPMENT, 2004, 18 (12) :1413-1422
[4]   Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes [J].
Ayrault, O ;
Andrique, L ;
Larsen, CJ ;
Seite, P .
ONCOGENE, 2004, 23 (49) :8097-8104
[5]   DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis [J].
Bartkova, J ;
Horejsi, Z ;
Koed, K ;
Krämer, A ;
Tort, F ;
Zieger, K ;
Guldberg, P ;
Sehested, M ;
Nesland, JM ;
Lukas, C ;
Orntoft, T ;
Lukas, J ;
Bartek, J .
NATURE, 2005, 434 (7035) :864-870
[6]   Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23 [J].
Bertwistle, D ;
Sugimoto, M ;
Sherr, CJ .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (03) :985-996
[7]   Monoclonal antibodies to the mouse p19Arf tumor suppressor protein [J].
Bertwistle, D ;
Zindy, F ;
Sherr, CJ ;
Roussel, MF .
HYBRIDOMA AND HYBRIDOMICS, 2004, 23 (05) :293-300
[8]   Telomere shortening and tumor formation by mouse cells lacking telomerase RNA [J].
Blasco, MA ;
Lee, HW ;
Hande, MP ;
Samper, E ;
Lansdorp, PM ;
DePinho, RA ;
Greider, CW .
CELL, 1997, 91 (01) :25-34
[9]   A mechanism for inhibiting the SUMO pathway [J].
Boggio, R ;
Colombo, R ;
Hay, RT ;
Draetta, GF ;
Chiocca, S .
MOLECULAR CELL, 2004, 16 (04) :549-561
[10]   N-terminal processing:: the methionine aminopeptidase and Nα-acetyl transferase families [J].
Bradshaw, RA ;
Brickey, WW ;
Walker, KW .
TRENDS IN BIOCHEMICAL SCIENCES, 1998, 23 (07) :263-267